Triple

T19773024
Position Surface form Disambiguated ID Type / Status
Subject Ibrance E474934 entity
Predicate hasActiveIngredient P12771 FINISHED
Object palbociclib
Palbociclib is an oral cyclin-dependent kinase 4/6 (CDK4/6) inhibitor used in combination therapies to treat certain types of hormone receptor–positive, HER2-negative advanced or metastatic breast cancer.
 E474934 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: palbociclib | Statement: [Ibrance, hasActiveIngredient, palbociclib]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: palbociclib
Context triple: [Ibrance, hasActiveIngredient, palbociclib]
  • A. Ibrance
    Ibrance is a targeted oral cancer medication (palbociclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative advanced or metastatic breast cancer.
  • B. lapatinib
    Lapatinib is an oral small-molecule tyrosine kinase inhibitor used primarily to treat HER2-positive breast cancer.
  • C. Lynparza
    Lynparza is a targeted cancer therapy (a PARP inhibitor) used primarily to treat certain types of ovarian, breast, pancreatic, and prostate cancers associated with BRCA mutations.
  • D. Talycopa
    Talycopa is a locality or area within the community of Llansamlet in Swansea, Wales.
  • E. Verzenio
    Verzenio is a prescription cancer medication (abemaciclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative breast cancer.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: palbociclib
Triple: [Ibrance, hasActiveIngredient, palbociclib]
Generated description
Palbociclib is an oral cyclin-dependent kinase 4/6 (CDK4/6) inhibitor used in combination therapies to treat certain types of hormone receptor–positive, HER2-negative advanced or metastatic breast cancer.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: palbociclib
Target entity description: Palbociclib is an oral cyclin-dependent kinase 4/6 (CDK4/6) inhibitor used in combination therapies to treat certain types of hormone receptor–positive, HER2-negative advanced or metastatic breast cancer.
  • A. Ibrance chosen
    Ibrance is a targeted oral cancer medication (palbociclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative advanced or metastatic breast cancer.
  • B. lapatinib
    Lapatinib is an oral small-molecule tyrosine kinase inhibitor used primarily to treat HER2-positive breast cancer.
  • C. Lynparza
    Lynparza is a targeted cancer therapy (a PARP inhibitor) used primarily to treat certain types of ovarian, breast, pancreatic, and prostate cancers associated with BRCA mutations.
  • D. Talycopa
    Talycopa is a locality or area within the community of Llansamlet in Swansea, Wales.
  • E. Verzenio
    Verzenio is a prescription cancer medication (abemaciclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative breast cancer.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8e51a43a08190956bc6df13c91a77 completed April 10, 2026, 11:55 a.m.
NER Named-entity recognition batch_69e6535e450c8190a2628245ae0d0bd3 completed April 20, 2026, 4:25 p.m.
NED1 Entity disambiguation (via context triple) batch_6a07c4f4618481908fafb84937c2143f completed May 16, 2026, 1:14 a.m.
NEDg Description generation batch_6a07c628176481908e636e80445facbc completed May 16, 2026, 1:19 a.m.
NED2 Entity disambiguation (via description) batch_6a07c69e228c8190a3f5b0dfc2c3a829 completed May 16, 2026, 1:21 a.m.
Created at: April 10, 2026, 1:48 p.m.